Skip to content
Review Open access

Persistent IFN-I signaling associated with the HIV-1 reservoir fuels immune exhaustion and reveals therapeutic targets

Aug 2026 · Frontiers in Immunology · Vol 17 · 0 citations · 82 references
Medicine

TL;DR

This review systematically examines the molecular and cellular mechanisms by which the HIV-1 reservoir fuels immune exhaustion through the IFN-I signaling pathway, providing a theoretical framework for the development of novel therapeutic strategies aimed at reservoir elimination or reversal of immune exhaustion.

Abstract

The viral reservoir established after HIV-1 infection remains the primary barrier to curing HIV. Recent studies suggest that proviral HIV-1 DNA, low-level viral transcripts, and other reservoir-derived viral products may contribute to persistent innate immune activation and type I interferon (IFN-I)-related inflammatory programs. This sustained activation drives a state of chronic immune activation, which induces and maintains exhaustion in immune cells such as CD4+ T cells. Exhaustion is characterized by loss of effector function and upregulation of inhibitory receptors (immune checkpoints), severely compromising the host’s antiviral immune response. In this review, we systematically examine the molecular and cellular mechanisms by which the HIV-1 reservoir fuels immune exhaustion through the IFN-I signaling pathway. We further explore potential intervention targets along this pathway, providing a theoretical framework for the development of novel therapeutic strategies aimed at reservoir elimination or reversal of immune exhaustion.

Read PDF

Similar papers

Jul 2026

Immune checkpoint blockade enhances CD4 effector function and enables control of persistent viral infection 2310195

A previously unrecognized and novel, IL-27—independent CD4+ T cell axis through which PD-1 checkpoint blockade restores antiviral immunity during persistent viral infection is revealed, redefining the mechanistic landscape of checkpoint immunotherapy.

Prajakta Warang, J. Teijaro · 0 citations
Open access Aug 2026

Innate Antiviral Immunity as a Double-Edged Determinant of Oncolytic Virotherapy Outcomes

Instead of seeking maximal viral replication or maximal innate immune activation, future OVT approaches should aim to define a productive immune window that supports viral oncolysis while preserving the inflammatory signals needed for durable antitumor immunity.

Alexander T. Roberts, Efraín E. Rivera-Serrano · 0 citations
Jul 2026

Interferon-Associated Antiviral Programs Define LAG-3+ Exhaustion-Like CD8+ T-Cell Remodeling in Influenza a Virus Infection: An Integrative Single-Cell and Multi-Cohort Analysis.

IAV infection is characterized by an interferon-dominated program and expansion of dysfunctional LAG-3+ CD8+ T cells, highlighting candidate biomarkers for immune remodeling.

Ye-Feng Zhou, Jia-Ning Wang, Jingyan Xu et al. · 0 citations
#gene editing Review Open access Sep 2026

Unveiling the role of extracellular vesicles in HIV infection: molecular mechanisms, viral persistence, and therapeutic opportunities

The molecular mechanisms through which EVs have been proposed to contribute to HIV infection are examined, focusing on host–virus interactions, immune regulation, chronic inflammation, and viral latency.

Flora Salzano, Nicoletta Capuano, F. Giordano et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.